2026 International HBV Meeting

活动简介:

Novotech will be attending the 2026 International HBV Meeting in Singapore as a Gold Sponsor. Meet with our team to discuss clinical development strategies for HBV and HDV programs, including trial design, regional study execution across Asia-Pacific, and operational considerations for antiviral and cure-focused therapies.

Meet the Novotech Team:

• Tom Hickey, Director, Therapeutic Strategy
• Andreas Kroemer, Project Oversight Director
• Bableen Gambhir, Business Development Director

If you're attending the meeting, we'd welcome the opportunity to discuss your HBV or HDV development program. Schedule a meeting using the form on this page.